Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01731782 · ClinicalTrials.gov registry record · NA

Evaluation of a TAP Block Given During Laparoscopic Colorectal Surgery to Help Control Pain

A NA study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
79
Enrollment target

NCT01731782 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 79 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01731782, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target

Study Summary

Patients experience pain after surgery mostly from their abdominal wounds, even when those wounds are small. Decreasing that pain has many benefits. It improves comfort, decreases stress response and might improve the outcome of the surgery. Local anesthesia (which is a numbing agent given directly at the site of pain via a needle) is given to decrease the pain that is felt after surgery and decrease the need for strong pain medications which can have negative side effects. One promising way to give local pain medication is called the "transversus abdominis plane" or TAP block. This method works by directly blocking the nerves in the abdomen that are the cause of the pain patients feel in their incision after surgery. This is done by injecting a numbing agent (Bupivacaine) into the area of their abdomen where their nerves are located that cause pain. In the case of nerves that carry sensation, bupivacaine blocks the pain sensation traveling in a particular nerve. Patients will be randomized (like a flip of a coin) to receive either a normal saline injection or the bupivacaine injection. The purpose of this study will be to prove the effectiveness of local anesthetic given via a TAP block in improving postoperative pain, decreasing the use of pain medications, decreasing postoperative nausea and vomiting and improve surgical outcomes such as hospital length of stay in laparoscopic colorectal surgery.

Interventions

  • DRUG bupivacaine
  • DRUG normal saline placebo (for bupivacaine)

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2012-07
Est. Completion 2014-08
Phase NA

What the Registry Record Tells You About NCT01731782

The ClinicalTrials.gov registry entry for NCT01731782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which bupivacaine is the first listed.

NCT01731782 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01731782 about?

NCT01731782 is a clinical study titled "Evaluation of a TAP Block Given During Laparoscopic Colorectal Surgery to Help Control Pain". Patients experience pain after surgery mostly from their abdominal wounds, even when those wounds are small. Decreasing that pain has many benefits. It improves comfort, decreases stress response and might improve the outcome of the surgery. Local anesthesia (which is a numbing agent given directly ...

What is the current status of trial NCT01731782?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2012-07. Estimated completion is 2014-08.

What interventions are being tested in trial NCT01731782?

The interventions under investigation include: bupivacaine (DRUG), normal saline placebo (for bupivacaine) (DRUG).

Who is sponsoring clinical trial NCT01731782?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.